XML 11 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue:    
Total revenue $ 172,325 $ 44,846
Operating expenses:    
Cost of sales 20,209 7,809
Research and development 84,701 110,027
Selling, general and administrative 129,505 102,093
Total operating expenses: 234,415 219,929
Net operating loss (62,090) (175,083)
Interest income 3,303 5,393
Interest expense (6,967) (7,529)
Other (expense)/ income, net (499) (277)
Net loss before taxes (66,253) (177,496)
Income tax expense 170 282
Net loss (66,423) (177,778)
Other comprehensive gain/(loss):    
Foreign currency translation 17 100
Total other comprehensive income 17 100
Comprehensive loss, net of tax $ (66,406) $ (177,678)
Net loss per common share, basic $ (0.54) $ (1.56)
Net loss per common share, diluted $ (0.54) $ (1.56)
Weighted-average number of common shares used in net loss per common share, basic 122,957 113,872
Weighted-average number of common shares used in net loss per common share, diluted 122,957 113,872
Product revenue, net [Member]    
Revenue:    
Total revenue $ 163,075 $ 38,800
Licensing and other revenue [Member]    
Revenue:    
Total revenue $ 9,250 $ 6,046